Hepatotoxicity and cutaneous reactions after antithyroid drug administration

Clinical Endocrinology

Volumn 77, Issue 2, 2012, Pages 310-315

  Otsuka, Fumiko ^a,b   Noh, Jaeduk Y ^a   Chino, Toshiko ^a   Shimizu, Taeko ^a   Mukasa, Koji ^a   Ito, Kunihiko ^a   Ito, Koichi ^a   Taniyama, Matsuo ^b  

^a ITO HOSPITAL   (Japan)

^b SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROPYLTHIOURACIL; THIAMAZOLE;

ADULT; AGED; AGRANULOCYTOSIS; ARTHRALGIA; ARTICLE; ATTENTION; CONTROLLED STUDY; DRUG CROSS REACTIVITY; DRUG ERUPTION; EOSINOPHILIA; FEMALE; FEVER; GRAVES DISEASE; HUMAN; LIVER DYSFUNCTION; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MYALGIA; NEUTROPENIA; PRIORITY JOURNAL; PRURITUS; PURPURA; SKIN MANIFESTATION;

ADOLESCENT; ADULT; AGED; ANTITHYROID AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GRAVES DISEASE; HUMANS; LIVER; MALE; METHIMAZOLE; MIDDLE AGED; PROPYLTHIOURACIL; SKIN; YOUNG ADULT;

EID: 84863698863     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2012.04365.x     Document Type: Article

References (16)

1. Cooper, D.S., (1999) The side effect of antithyroid drugs. The Endocrinologist, 9, 457-467.
2. Nakamura, H., Noh, J.Y., Itoh, K., et al,. (2007) Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. The Journal of Clinical Endocrinology and Metabolism, 92, 2157-2162.
3. Abraham, P., Avenell, A., McGeoch, S.C., et al,. (2010) Antithyroid drug regimen for treating Graves' hyperthyroidism. The Cochrane Database of Systematic Reviews, 1, CD003420.
4. Liaw, Y.F., Huang, M.J., Fan, K.D., et al,. (1993) Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism. A cohort study. Annals of Internal Medicine, 118, 424-428.
5. Werner, M.C., Romaldini, J.H., Bromberg, N., et al,. (1989) Adverse effects related to thionamide drugs and their dose regimen. American Journal of the Medical Sciences, 297, 216-219.
6. Bahn Chair, R.S., Burch, H.B., Cooper, D.S., et al,. (2011) Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid, 21, 593-646.
7. Ghabril, M., Chalasani, N., &, Björnsson, E., (2010) Drug-induced liver injury: a clinical update. Current Opinion in Gastroenterology, 26, 222-226.
8. Tsukamoto, N., Otsuka, F., Suzuki, J., et al,. (2011) A case of fulminant hepatitis caused by antithyroid drug treatment where the life could be saved by liver transplant [in Japanese]. Nihon Naibunpi Gakkai Zasshi, 87 (Suppl), 35-37.
9. Kim, H.J., Kim, B.H., Han, Y.S., et al,. (2001) The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study. American Journal of Gastroenterology, 96, 165-169.
10. Pearce, S.H., (2004) Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK. Clinical Endocrinology (Oxford), 61, 589-594.
11. Huang, M.J., &, Liaw, Y.F., (1995) Clinical associations between thyroid and liver diseases. Journal of Gastroenterology and Hepatology, 10, 344-350.
12. Bayraktar, M., &, Van Thiel, D.H., (1997) Abnormalities in measures of liver function and injury in thyroid disorders. Hepato-Gastroenterology, 44, 1614-1618.
13. Biscoveanu, M., &, Hasinski, S., (2000) Abnormal results of liver function tests in patients with Graves'disease. Endocrine Practice, 6, 367-369.
14. Chen, B., Lang, R., Jutrin, Y., et al,. (1983) Recurrent agranulocytosis induced by two different antithyroid agents. The Medical Journal of Australia, 2, 38-39.
15. Ostlere, S., &, Apthorp, G.H., (1988) Recurrent agranulocytosis following carbimazole and propylthiouracil therapy. The British Journal of Clinical Practice, 42, 474-475.
16. Ahmed, K., Rao, S., &, Simha, V., (2010) Antineutrophil cytoplasmic antibody-positive vasculitis in a patient with Graves' disease: cross-reaction between propylthiouracil and methimazole. Endocrine Practice, 16, 449-451.